Calidi Biotherapeutics, Inc. Depreciation
Calidi Biotherapeutics, Inc. (CLDI) reported Depreciation of $91.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2025-05-14
- Calidi Biotherapeutics, Inc. depreciation for the quarter ending 2025-03-31 was $91.00K, a 10.78% decline year-over-year.
- Calidi Biotherapeutics, Inc. depreciation for the quarter ending 2024-12-31 was $98.00K, a 1.01% decline year-over-year.
- Calidi Biotherapeutics, Inc. depreciation for the quarter ending 2024-09-30 was $100.00K, a 0.00% change year-over-year.
- Calidi Biotherapeutics, Inc. depreciation for the quarter ending 2024-06-30 was $100.00K, a 0.00% change year-over-year.
- Calidi Biotherapeutics, Inc. depreciation for fiscal 2024 was $402.00K, a 2.55% increase from fiscal 2023.
- Calidi Biotherapeutics, Inc. depreciation for fiscal 2023 was $392.00K, a 50.77% increase from fiscal 2022.
- Calidi Biotherapeutics, Inc. depreciation for fiscal 2022 was $260.00K.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2025-03-31 | $91.00K 10-Q · filed 2025-05-14 | $189.00K derived: sum of 2 quarters · filed 2025-05-14 | $289.00K derived: sum of 3 quarters · filed 2025-05-14 | $389.00K derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-12-31 | $98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $198.00K derived: sum of 2 quarters · filed 2025-03-31 | $298.00K derived: sum of 3 quarters · filed 2025-03-31 | $402.00K 10-K · filed 2025-03-31 |
| 2024-09-30 | $100.00K 10-Q · filed 2024-11-12 | $200.00K derived: sum of 2 quarters · filed 2024-11-12 | $304.00K 10-Q · filed 2024-11-12 | $401.00K derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-06-30 | $100.00K 10-Q · filed 2024-08-13 | $202.00K 10-Q · filed 2024-08-13 | $301.00K derived: sum of 3 quarters · filed 2025-05-14 | $401.00K derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-03-31 | $102.00K 10-Q · filed 2025-05-14 | $201.00K derived: sum of 2 quarters · filed 2025-05-14 | $301.00K derived: sum of 3 quarters · filed 2025-05-14 | $401.00K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $99.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $199.00K derived: sum of 2 quarters · filed 2025-03-31 | $299.00K derived: sum of 3 quarters · filed 2025-03-31 | $392.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $100.00K 10-Q · filed 2024-11-12 | $200.00K derived: sum of 2 quarters · filed 2024-11-12 | $293.00K 10-Q · filed 2024-11-12 | $391.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $100.00K 10-Q · filed 2024-08-13 | $206.00K 10-Q · filed 2024-08-13 | $291.00K derived: sum of 3 quarters · filed 2024-08-13 | $391.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $93.00K 10-Q · filed 2024-05-14 | $191.00K derived: sum of 2 quarters · filed 2024-05-14 | $291.00K derived: sum of 3 quarters · filed 2024-05-14 | |
| 2022-12-31 | $98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $198.00K derived: sum of 2 quarters · filed 2024-03-15 | $260.00K 10-K · filed 2024-03-15 | |
| 2022-09-30 | $100.00K 10-Q · filed 2023-11-14 | $162.00K 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |